Disease burden of ATTR amyloidosis based on the SF-36® health survey
Abstract Transthyretin (ATTR) amyloidosis is a progressive systemic disease associated with substantial morbidity and mortality. Although health-related quality of life (HRQoL) assessments are increasingly incorporated into clinical trials, data in ATTR amyloidosis remain limited. We conducted a ret...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2026-04-01
|
| Series: | Cardio-Oncology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s40959-026-00482-2 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|